TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 NOK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
17,573
|
14,877
|
13,143 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
175
|
682
|
345 |
| EBITDA |
429
|
901
|
558 |
| Total assets |
6,299
|
6,220
|
5,317 |
| Current assets |
5,455
|
5,525
|
4,473 |
| Current liabilities |
2,252
|
2,009
|
1,520 |
| Equity capital |
3,834
|
3,963
|
3,537 |
| - share capital |
54
|
50
|
52 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
60.9%
|
63.7%
|
66.5% |
| Turnover per employee |
4,393
|
3,719
|
4,381 |
| Profit as a percentage of turnover |
1.0%
|
4.6%
|
2.6% |
| Return on assets (ROA) |
2.8%
|
11.0%
|
6.5% |
| Current ratio |
242.2%
|
275.0%
|
294.3% |
| Return on equity (ROE) |
4.6%
|
17.2%
|
9.8% |
| Change turnover |
1,645
|
2,132
|
875 |
| Change turnover % |
10%
|
17%
|
7% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.